Episode 373 -- Christian Focacci on Current Developments in AI and Risk Management
Law School Toolbox Podcast Episode 507: What Do I Need to Do Before the First Day of Law School? (1L Summer Series)
Meet Phil Leslie, Cornerstone Research's New Chief Technology and Innovation Officer
London Partner Roberta Downey Wired for Disputes: Tech, Infrastructure, and the New Frontier of Risk
Law School Toolbox Podcast Episode 505: Breaking ADHD Barriers with the Help of AI (w/Lindsay Scola)
No Password Required: CEO of HACKERverse.ai, Disruptor of Cybersecurity Sales and Most Other Things
(Podcast) The Briefing: No CTRL-ALT-DEL For the Server Test
Compliance Tip of the Day – Role of Chatbots in Compliance
5 Key Takeaways | AI and Your Patent Management, Strategy & Portfolio
(Podcast) The Briefing: The Future of TV? A 2025 Digital Media Trends Analysis
The Privacy Insider Podcast Episode 13: Preserving Privacy and Social Connection with Christine Rosen of the American Enterprise Institute
Great Women in Compliance: Creating Space to Speak Up: The Story Behind Psst.org
JONES DAY TALKS®: Women in IP – AI and Copyright Law Need-to-Knows
No Password Required: SVP at SpyCloud Labs, Former Army Investigator, and Current Breakfast Champion
Compliance into the Weeds: The Role of Compliance Going Forward
A Less is More Strategy for Data Risk Mitigation
Third-Party Risk The competitive world of banking struggles to keep up with technological advances, particularly in a regulatory environment.
Investment Opportunities in Italy's Tech Market
The AI Shakeup: New Tech Innovations and the Future of Corporate Law
Regulatory Ramblings: Episode 44 - The Dangers of Non-Technically Trained Lawyers Advising on Technological Matters with Ronald Yu and Donald Day
On May 23, 2025, President Donald Trump signed four executive orders aimed at revitalizing and accelerating the growth of nuclear energy in the United States. The executive orders direct actions by the Department of Defense...more
The top legal issues in 2024 for the life sciences field reflect the complex and changing legal landscape that the industry is navigating, encompassing drug pricing, regulatory challenges, and broader societal and governance...more